The three-biomarker panel contains EIF5A, IL4R, and SLC9A8 that interestingly had the higher LASSO values compared to other features and were altered with fold changes of 0.68, 1.42, and 1.46, respectively in IBD (Figure 5A). This evidence concerns the gene SLC9A8 and inflammatory bowel disease.